I studied medicine at Cambridge and Oxford before training in psychiatry in the Oxford region. My academic training was supported by a Wellcome Trust Research Training Fellowship and a NIHR Clinical Lectureship.
While a Clinical Senior Lecturer at IOPPN, I worked as a consultant psychiatrist for South London and Maudsley NHS Foundation Trust, and served as Associate Clinical Director for the Early Intervention pathway. I now work as a consultant for the Adult Mental Health Team in West Oxfordshire.
My research interests have included using advanced meta-analysis of clinical trial data to clarify treatment mechanisms, and also understanding vulnerability and resilience mechanisms, and potential diagnostic markers, through techniques such as Magnetic Resonance Spectroscopy.
Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study.
Merritt K. et al, (2020), J Psychopharmacol, 34, 839 - 847
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.
Beck K. et al, (2020), JAMA Netw Open, 3
TRAVERSING THE TRANSDIAGNOSTIC GAP BETWEEN DEPRESSION, MANIA AND PSYCHOSIS WITH NATURAL LANGUAGE PROCESSING
Patel R. et al, (2020), SCHIZOPHRENIA BULLETIN, 46, S272 - S273
Applying economic models to estimate local economic benefits of improved coverage of early intervention for psychosis
Campion J. et al, (2019), Early Intervention in Psychiatry, 13, 1424 - 1430
Should we challenge the way we assess functioning?
Taylor M., (2019), EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S594 - S594